# Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study

> **NCT01586858** · — · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 67 (actual)

## Conditions studied

- Granulomatosis With Polyangiitis
- Microscopic Polyangiitis

## Interventions

- **OTHER:** Observational

## Key facts

- **NCT ID:** NCT01586858
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05
- **Primary completion:** 2014-05-15
- **Final completion:** 2014-05-15
- **Target enrollment:** 67 (ACTUAL)
- **Why stopped:** Loss of Funding
- **Last updated:** 2017-10-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01586858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01586858, "Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01586858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*